Virtu KCG Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-2,500
Closed -$349K 3018
2015
Q4
$349K Hold
2,500
0.01% 1970
2015
Q3
$350K Buy
2,500
+1,200
+92% +$180K 0.01% 1900
2015
Q2
$213K Sell
1,300
-500
-28% -$79.9K ﹤0.01% 2507
2015
Q1
$278K Sell
1,800
-4,500
-71% -$641K 0.01% 1994
2014
Q4
$792K Sell
6,300
-600
-9% -$74.1K 0.01% 1181
2014
Q3
$825K Sell
6,900
-8,200
-54% -$941K 0.02% 1140
2014
Q2
$1.63M Sell
15,100
-48,600
-76% -$5.01M 0.03% 696
2014
Q1
$6.34M Buy
63,700
+53,300
+513% +$4.82M 0.08% 194
2013
Q4
$961K Sell
10,400
-9,300
-47% -$826K 0.01% 1268
2013
Q3
$1.65M Buy
+19,700
New +$1.69M 0.02% 758

Other funds holding ELV

Virtu KCG Holdings's ELV Position: Q2 2017 in Review

Virtu KCG Holdings increased its Elevance Health (ELV) stake by 29% in Q2 2017, buying an estimated $1.18M and bringing the position to 28,959 shares worth $5.45M. The position accounts for 0.15% of the portfolio, ranked #55.

Virtu KCG Holdings first reported a position in ELV in Q3 2013 and has held it in 16 quarters since. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Virtu KCG Holdings held 28,959 shares of Elevance Health worth $5.45M as of Q2 2017.
  • Virtu KCG Holdings bought 6,542 Elevance Health shares in Q2 2017, an estimated $1.18M.
  • Elevance Health made up 0.15% of Virtu KCG Holdings's portfolio in Q2 2017, its #55 holding.
  • Virtu KCG Holdings first reported a position in Elevance Health in Q3 2013 and has held it in 16 quarters since.
  • 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.